Loopbaan van Alan F. Wahl
Eerdere bekende functies van Alan F. Wahl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-01-2011 | 01-12-2013 |
| SEAGEN INC. | Corporate Officer/Principal | 01-05-1998 | 01-05-2006 |
| AMBRX INC | Hoofd Techniek/Wetenschap/O&O | 01-12-2013 | - |
Opleiding van Alan F. Wahl
| Rochester Christian University | Doctorate Degree |
| Rochester Institute of Technology | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Alan F. Wahl
- Ervaring
